PCN3I EVALUATION OF PEMETREXED VERSUS DOCETAXEL IN THE SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER- PATIENT PREFERENCE AND WILLINGNESS-TO-PAYWITH DISCRETE CHOICE CONJOINT ANALYSIS
Nov 1, 2004, 00:00 AM
10.1016/S1098-3015(10)65764-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65764-6/fulltext
Section Title :
Section Order :
131
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65764-6&doi=10.1016/S1098-3015(10)65764-6